跳至主要内容
临床试验/ISRCTN76916228
ISRCTN76916228已完成未知

Effect of combined exercise therapy and isoflavone supplementation on prevention of osteoporosis: a randomised controlled trial

niversity of Saskatchewan (Canada)0 个研究点目标入组 360 人开始时间: 2005年9月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
360

研究概览

简要总结

  1. 2013 results in https://www.ncbi.nlm.nih.gov/pubmed/23165609 (added 01/02/2019)

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • Post-menopausal women (age range of approximately 45 to 70 years)

排除标准

  • 1. Diagnosed osteoporosis
  • 2. Previous fragility fractures
  • 3. Above normal bone mineral density (equal to or above the young adult mean)
  • 4. Breast or endometrial cancers
  • 5. Women taking bisphosphonates, hormone replacement therapy, selective estrogen receptor modulators, parathyroid hormone (PTH), or calcitonin in the past 12 months
  • 6. Taking corticosteroids or diuretics
  • 7. Diagnosed Crohn?s Disease and Cushing Disease
  • 8. Women with allergies to soy
  • 9. Severe osteoporosis
  • 10. Smokers
  • 11. Currently participating in vigorous exercise programs

研究者

发起方
niversity of Saskatchewan (Canada)

相似试验